Treating resistant hypertension in type 2 diabetes: a role for spironolactone?

This publication has 13 references indexed in Scilit:

• Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
  New England Journal of Medicine, 2004
• Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
  Journal of Human Hypertension, 2004
• The role of spironolactone in the treatment of patients with refractory hypertension
  American Journal of Hypertension, 2002
• Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
  The American Journal of Cardiology, 1993
• Aldactazine/captopril combination, safe and effective in mild to moderate systemic hypertension: Report on a multicenter study of 967 patients
  The American Journal of Cardiology, 1990
• Spironolactone versus nifedipine in essential hypertension
  The American Journal of Cardiology, 1990
• Hyperkalaemia in diabetes mellitus—potential hazards of coexisting hyporeninaemic hypoaldosteronism
  Published by Oxford University Press (OUP) ,1984
• The Effect of Spironolactone on Lipid, Glucose and Uric Acid Levels in Blood during Long‐Term Administration to Hypertensives
  Acta Medica Scandinavica, 1983
• Antihypertensive Actions of Diuretics
  Published by American Medical Association (AMA) ,1968
• Treatment of Arterial Hypertensive Disease With Diuretics
  Archives of internal medicine (1960), 1967